BOXL vs NVDA

The Advanced Deterministic Scorecard reveals a critically weak financial profile with a Piotroski F-Score of just 1/9, indicating severe deterioration in fundamental health. The company is unprofitable with negative margins across all key metrics, a deeply negative Price/Book ratio, and a Debt/Equity ratio of 4.92, far exceeding sector averages. Revenue has declined by 19.2% year-over-year, cash flow data is unavailable, and insider activity shows net selling. Despite a recent 1-week price rebound of 17%, the 5-year return of -99.7% underscores a prolonged collapse in market confidence.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.